The epidemiology of travelers' diarrhea in Incirlik, Turkey: A region with a predominance of heat-stabile toxin producing enterotoxigenic Escherichia coli

Diagnostic Microbiology and Infectious Disease

Volumn 66, Issue 3, 2010, Pages 241-247

  Porter, Chad K ^a   Riddle, Mark S ^a   Tribble, David R ^b   Putnam, Shannon D ^c   Rockabrand, David M ^d   Frenck, Robert W ^d   Rozmajzl, Patrick ^d   Kilbane, Edward ^d   Fox, Ann ^e   Ruck, Richard ^f   Lim, Matthew ^f   Johnston, James ^d   Murphy, Emmett ^g   Sanders, John W ^d  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

^d US Naval Medical Research Unit No 3 Egypt   (Egypt)

^e Oak Harbor Naval Hospital   (United States)

^f WALTER REED ARMY MEDICAL CENTER   (United States)

^g Medical Center   (United States)

Author keywords

Enteric disease; Travelers' diarrhea

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL TOXIN; BISMUTH SALICYLATE; CIPROFLOXACIN; COTRIMOXAZOLE; LEVOFLOXACIN; LOPERAMIDE; NALIDIXIC ACID; TETRACYCLINE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARMY; ARTICLE; CAMPYLOBACTER; ENTEROTOXIGENIC ESCHERICHIA COLI; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUESTIONNAIRE; TRAVELLER DIARRHEA; TURKEY (REPUBLIC);

ADULT; ANTI-INFECTIVE AGENTS; ANTIDIARRHEALS; BACTERIAL TOXINS; CHI-SQUARE DISTRIBUTION; DIARRHEA; ENTEROTOXIGENIC ESCHERICHIA COLI; ENTEROTOXINS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MILITARY PERSONNEL; PROSPECTIVE STUDIES; RISK FACTORS; TRAVEL; TURKEY;

EID: 77349093269     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.10.002     Document Type: Article

References (44)

1. Binsztein N., Jouve M.J., et al. Colonization factors of enterotoxigenic Escherichia coli isolated from children with diarrhea in Argentina. J. Clin. Microbiol. 1991, 29:1893-1898.
2. Bopp C.A., Brenner F.W., et al. Escherichia, Shigella, and Salmonella. Manual of clinical microbiology 1999, 459-474. American Society for Microbiology, Washington, DC. P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tenover, R.H. Yolken (Eds.).
3. Chapin A.R., Carpenter C.M., et al. Prevalence of norovirus among visitors from the United States to Mexico and Guatemala who experience traveler's diarrhea. J. Clin. Microbiol. 2005, 43:1112-1117.
4. Connor P., Farthing M.J. Travellers' diarrhoea: a military problem?. J. R. Army Med. Corps. 1999, 145:95-101.
5. Ergonul O., Imre A., et al. Drug resistance of Shigella species: changes over 20 years in Turkey. Int. J. Antimicrob. Agents 2004, 23:527-528.
6. Evans M.R., Northey G., et al. Short-term and medium-term clinical outcomes of quinolone-resistant Campylobacter infection. Clin. Infect. Dis. 2009, 48:1500-1506.
7. Farmer J.J. Enterobacteriaceae: introduction and identification. Manual of clinical microbiology 1999, 442-458. American Society for Microbiology, Washington, DC. P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tenover, R.H. Yolken (Eds.).
8. Galbadage T., Jiang Z.D., et al. Improvement in detection of enterotoxigenic Escherichia coli in patients with travelers' diarrhea by increasing the number of E. coli colonies tested. Am. J. Trop. Med. Hyg. 2009, 80:20-23.
9. Gallardo F., Gascon J., et al. Campylobacter jejuni as a cause of traveler's diarrhea: clinical features and antimicrobial susceptibility. J. Travel Med. 1998, 5:23-26.
10. Gupta S.K., Keck J., et al. Part III. Analysis of data gaps pertaining to enterotoxigenic Escherichia coli infections in low and medium human development index countries, 1984-2005. Epidemiol. Infect. 2007, 1-18.
11. Hoge C.W., Shlim D.R., et al. Epidemiology of diarrhea among expatriate residents living in a highly endemic environment. JAMA 1996, 275:533-538.
12. Hürriyet (2006). Anadolu Agency. "Tourism statistics for 2005", Hürriyet, 2006-01-27. Accessed via on 11 June 2007. http://www.arama.hurriyet.com.tr/arsivnews.aspx?id=3852067.
13. Hyams K.C., Bourgeois A.L., et al. Diarrheal disease during Operation Desert Shield. N. Engl. J. Med. 1991, 325:1423-1428.
14. Hyams K.C., Hanson K., et al. The impact of infectious diseases on the health of U.S. troops deployed to the Persian Gulf during operations Desert Shield and Desert Storm. Clin. Infect. Dis. 1995, 20:1497-1504.
15. Jiang X., Wilton N., et al. Diagnosis of human caliciviruses by use of enzyme immunoassays. J. Infect. Dis. 2000, 181(Suppl 2):S349-S359.
16. Ko G., Garcia C., et al. Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico. J. Clin. Microbiol. 2005, 43:6126-6129.
17. Meraz I.M., Jiang Z.D., et al. Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea-a PCR-based study. J. Travel Med. 2008, 15:412-418.
18. Monteville M.R., Riddle M.S., et al. Incidence, etiology, and impact of diarrhea among deployed US military personnel in support of Operation Iraqi Freedom and Operation Enduring Freedom. Am. J. Trop. Med. Hyg. 2006, 75:762-767.
19. National Committee for Clinical Laboratory Standards (NCCLS) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 2000, Wayne, PA.
20. Nelson J.M., Smith K.E., et al. Prolonged diarrhea due to ciprofloxacin-resistant Campylobacter infection. J. Infect. Dis. 2004, 190:1150-1157.
21. Oyofo B.A., el-Gendy A., et al. A survey of enteropathogens among United States military personnel during Operation Bright Star '94, in Cairo, Egypt. Mil. Med. 1995, 160:331-334.
22. Oyofo B.A., Peruski L.F., et al. Enteropathogens associated with diarrhea among military personnel during Operation Bright Star 96, in Alexandria, Egypt. Mil. Med. 1997, 162:396-400.
23. Ozmert E.N., Gokturk B., et al. Shigella antibiotic resistance in central Turkey: comparison of the years 1987-1994 and 1995-2002. J. Pediatr. Gastroenterol. Nutr. 2005, 40:359-362.
24. Patel M.M., Widdowson M.A., et al. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg. Infect. Dis. 2008, 14:1224-1231.
25. Putnam S.D., Sanders J.W., et al. Self-reported description of diarrhea among military populations in operations Iraqi Freedom and Enduring Freedom. J. Travel Med. 2006, 13:92-99.
26. Qadri F., Das S.K., et al. Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh. J. Clin. Microbiol. 2000, 38:27-31.
27. Qadri F., Svennerholm A.M., et al. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin. Microbiol. Rev. 2005, 18:465-483.
28. Rao M.R., Abu-Elyazeed R., et al. High disease burden of diarrhea due to enterotoxigenic Escherichia coli among rural Egyptian infants and young children. J. Clin. Microbiol. 2003, 41:4862-4864.
29. Riddle M.S., Sanders J.W., et al. Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review. Am. J. Trop. Med. Hyg. 2006, 74:891-900.
30. Ryan E.T., Kain K.C. Health advice and immunizations for travelers. N. Engl. J. Med. 2000, 342:1716-1725.
31. Sanchez J., Holmgren J., et al. Recombinant fusion protein for simple detection of Escherichia coli heat-stable enterotoxin by GM1 enzyme-linked immunosorbent assay. J. Clin. Microbiol. 1990, 28:2175-2177.
32. Sanchez J.L., Gelnett J., et al. Diarrheal disease incidence and morbidity among United States military personnel during short-term missions overseas. Am. J. Trop. Med. Hyg. 1998, 58:299-304.
33. Sanders J.W., Putnam S.D., et al. The epidemiology of self-reported diarrhea in operations Iraqi freedom and enduring freedom. Diagn. Microbiol. Infect. Dis. 2004, 50:89-93.
34. Sanders J.W., Putnam S.D., et al. Impact of illness and non-combat injury during Operations Iraqi Freedom and Enduring Freedom (Afghanistan). Am. J. Trop. Med. Hyg. 2005, 73:713-719.
35. Sanders J.W., Putnam S.D., et al. Diarrheal illness among deployed U.S. military personnel during Operation Bright Star 2001-Egypt. Diagn. Microbiol. Infect. Dis. 2005, 52:85-90.
36. Sanders J.W., Frenck R.W., et al. Azithromycin and loperamide are comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in United States military personnel in Turkey. Clin. Infect. Dis. 2007, 45:294-301.
37. Sharp S.E., Suarez C.A., et al. Evaluation of the Triage Micro Parasite Panel for detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum in patient stool specimens. J. Clin. Microbiol. 2001, 39:332-334.
38. Steinsland H., Valentiner-Branth P., et al. Enterotoxigenic Escherichia coli infections and diarrhea in a cohort of young children in Guinea-Bissau. J. Infect. Dis. 2002, 186:1740-1747.
39. Svennerholm A.M., Wiklund G. Rapid GM1-enzyme-linked immunosorbent assay with visual reading for identification of Escherichia coli heat-labile enterotoxin. J. Clin. Microbiol. 1983, 17:596-600.
40. Tellier R., Keystone J.S. Prevention of traveler's diarrhea. Infect. Dis. Clin. North Am. 1992, 6:333-354.
41. Thornton S.A., Sherman S.S., et al. Gastroenteritis in US Marines during Operation Iraqi Freedom. Clin. Infect. Dis. 2005, 40:519-525.
42. Uysal G., Dogru U., et al. Campylobacter jejuni gastroenteritis in Turkish children. Infection 1997, 25:159-162.
43. Viboud G.I., Binsztein N., et al. Characterization of monoclonal antibodies against putative colonization factors of enterotoxigenic Escherichia coli and their use in an epidemiological study. J. Clin. Microbiol. 1993, 31:558-564.
44. World Tourism Organization Accessed May 7, 2009. http://www.unwto.org.